Indonesia Generics Market Summary, Competitive Analysis and Forecast to 2027
Indonesia Generics Market Summary, Competitive Analysis and Forecast to 2027
Summary
Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
Summary
Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2017-22, and forecast to 2027). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and branded generics are included in our market scope. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included. The market value is evaluated at ex-factory prices.
- The Indonesian generics market had total revenues of $1.5 billion in 2022, representing a compound annual growth rate (CAGR) of 10.2% between 2017 and 2022.
- Market consumption volume increased with a CAGR of 1.1% between 2017 and 2022, to reach a total of 50.7% in 2022.
- The consumption of generic medication is expanding due to its lower cost than patented original medications, giving them an edge in volume-based procurement settings where there is intense price rivalry.
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the generics market in Indonesia
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Indonesia
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Indonesia generics market with five year forecasts
- What was the size of the Indonesia generics market by value in 2022?
- What will be the size of the Indonesia generics market in 2027?
- What factors are affecting the strength of competition in the Indonesia generics market?
- How has the market performed over the last five years?
- What are the main segments that make up Indonesia's generics market?
1 EXECUTIVE SUMMARY
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 COMPANY PROFILES
8.1. PT Kalbe Farma Tbk
8.2. PT Sanbe Farma
8.3. PT Soho Global Health Tbk
8.4. PT Indofarma (Persero), Tbk
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape
2 MARKET OVERVIEW
2.1. Market definition
2.2. Market analysis
3 MARKET DATA
3.1. Market value
3.2. Market volume
4 MARKET SEGMENTATION
4.1. Geography segmentation
5 MARKET OUTLOOK
5.1. Market value forecast
5.2. Market volume forecast
6 FIVE FORCES ANALYSIS
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 COMPETITIVE LANDSCAPE
7.1. Who are the leading players?
7.2. What are the strengths of the leading players?
7.3. Have there been any recent developments in the market?
8 COMPANY PROFILES
8.1. PT Kalbe Farma Tbk
8.2. PT Sanbe Farma
8.3. PT Soho Global Health Tbk
8.4. PT Indofarma (Persero), Tbk
9 MACROECONOMIC INDICATORS
9.1. Country data
10 APPENDIX
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
LIST OF TABLES
Table 1: Indonesia generics market value: $ million, 2017-22
Table 2: Indonesia generics market volume: %, 2017-22
Table 3: Indonesia generics market geography segmentation: $ million, 2022
Table 4: Indonesia generics market value forecast: $ million, 2022-27
Table 5: Indonesia generics market volume forecast: %, 2022-27
Table 6: PT Kalbe Farma Tbk: key facts
Table 7: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 8: PT Kalbe Farma Tbk: Key Employees
Table 9: PT Sanbe Farma: key facts
Table 10: PT Sanbe Farma: Key Employees
Table 11: PT Soho Global Health Tbk: key facts
Table 12: PT Soho Global Health Tbk: Annual Financial Ratios
Table 13: PT Soho Global Health Tbk: Key Employees
Table 14: PT Indofarma (Persero), Tbk: key facts
Table 15: PT Indofarma (Persero), Tbk: Annual Financial Ratios
Table 16: PT Indofarma (Persero), Tbk: Key Employees
Table 17: Indonesia size of population (million), 2018-22
Table 18: Indonesia gdp (constant 2005 prices, $ billion), 2018-22
Table 19: Indonesia gdp (current prices, $ billion), 2018-22
Table 20: Indonesia inflation, 2018-22
Table 21: Indonesia consumer price index (absolute), 2018-22
Table 22: Indonesia exchange rate, 2018-22
Table 1: Indonesia generics market value: $ million, 2017-22
Table 2: Indonesia generics market volume: %, 2017-22
Table 3: Indonesia generics market geography segmentation: $ million, 2022
Table 4: Indonesia generics market value forecast: $ million, 2022-27
Table 5: Indonesia generics market volume forecast: %, 2022-27
Table 6: PT Kalbe Farma Tbk: key facts
Table 7: PT Kalbe Farma Tbk: Annual Financial Ratios
Table 8: PT Kalbe Farma Tbk: Key Employees
Table 9: PT Sanbe Farma: key facts
Table 10: PT Sanbe Farma: Key Employees
Table 11: PT Soho Global Health Tbk: key facts
Table 12: PT Soho Global Health Tbk: Annual Financial Ratios
Table 13: PT Soho Global Health Tbk: Key Employees
Table 14: PT Indofarma (Persero), Tbk: key facts
Table 15: PT Indofarma (Persero), Tbk: Annual Financial Ratios
Table 16: PT Indofarma (Persero), Tbk: Key Employees
Table 17: Indonesia size of population (million), 2018-22
Table 18: Indonesia gdp (constant 2005 prices, $ billion), 2018-22
Table 19: Indonesia gdp (current prices, $ billion), 2018-22
Table 20: Indonesia inflation, 2018-22
Table 21: Indonesia consumer price index (absolute), 2018-22
Table 22: Indonesia exchange rate, 2018-22
LIST OF FIGURES
Figure 1: Indonesia generics market value: $ million, 2017-22
Figure 2: Indonesia generics market volume: %, 2017-22
Figure 3: Indonesia generics market geography segmentation: % share, by value, 2022
Figure 4: Indonesia generics market value forecast: $ million, 2022-27
Figure 5: Indonesia generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Indonesia, 2022
Figure 7: Drivers of buyer power in the generics market in Indonesia, 2022
Figure 8: Drivers of supplier power in the generics market in Indonesia, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Indonesia, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Indonesia, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Indonesia, 2022
Figure 1: Indonesia generics market value: $ million, 2017-22
Figure 2: Indonesia generics market volume: %, 2017-22
Figure 3: Indonesia generics market geography segmentation: % share, by value, 2022
Figure 4: Indonesia generics market value forecast: $ million, 2022-27
Figure 5: Indonesia generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in Indonesia, 2022
Figure 7: Drivers of buyer power in the generics market in Indonesia, 2022
Figure 8: Drivers of supplier power in the generics market in Indonesia, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Indonesia, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in Indonesia, 2022
Figure 11: Drivers of degree of rivalry in the generics market in Indonesia, 2022
